Skip to main content
Equibles
NVST logo

NVST · Envista Holdings Corp · Metrics

Track NVST — free

Use NVST with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research NVST.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$23.97 +0.78 (+3.36%)
S&P 400 member Russell 1000 member Rebalance outlook locked
Market Cap
$3.72B
Shares
160.62M
Volume · Oct 22 3.37M Avg daily vol (3M) 2.87M

NVST metrics

109 of 122 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$23.19
Market cap
$3.72B

Price action

20 metrics
Price change (1W)
+1.6%
Price change (30D)
-4.1%
Price change (3M)
-12.3%
Price change (6M)
-14.6%
Price change (YTD)
+6.8%
Price change (1Y)
+15.5%
Trailing year
Price change (5Y)
-40.2%
52-week high
$30.26
52-week low
$18.95
Change from 52-week high
-23.4%
Change from 52-week low
+22.4%
Annualized volatility
37.7%
Annualized volatility (3M)
29.3%
Beta
1.2
RSI (14D)
44.1
Price vs SMA 50
-7.8%
Price vs SMA 200
-9.9%
Avg volume (3M)
2.87M
Relative volume
1.9
Average dollar volume
$73.67M

Company

3 metrics
Sector
Healthcare
Industry
Medical Instruments & Supplies
Shares outstanding
160.62M

Valuation

12 metrics
P / E (TTM)
40.0
Trailing earnings · reciprocal yield 2.5%
PEG ratio
0.4
EV / revenue
1.4×
reciprocal yield 72.1%
EV / EBITDA
10.2×
reciprocal yield 9.8%
EV / EBIT
14.5×
reciprocal yield 6.9%
P / sales
1.3×
reciprocal yield 76.7%
P / book
1.2
reciprocal yield 82.6%
FCF yield
6.7%
TTM · current market cap
Buyback yield
—
P / FCF
15.0
reciprocal yield 6.7%
P / operating cash flow
12.3
reciprocal yield 8.1%
Earnings yield
2.6%

Historical valuation

8 metrics
P / E historical average (3Y)
92.0×
reciprocal yield 1.1%
P / E historical average (5Y)
65.9×
reciprocal yield 1.5%
EV / revenue historical average (3Y)
1.5×
reciprocal yield 64.8%
EV / revenue historical average (5Y)
2.0×
reciprocal yield 49.6%
EV / EBIT historical average (3Y)
98.0×
reciprocal yield 1.0%
EV / EBIT historical average (5Y)
60.3×
reciprocal yield 1.7%
EV / EBITDA historical average (3Y)
13.1×
reciprocal yield 7.7%
EV / EBITDA historical average (5Y)
13.1×
reciprocal yield 7.7%

Dividends & buybacks

7 metrics
Dividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
—
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—

Earnings calendar

2 metrics
Next earnings
2026-11-04
Last earnings
2026-08-05

Profitability

9 metrics
Gross margin
55.2%
Operating margin
9.6%
Trailing 12 months
Net margin
3.3%
Gross profit (TTM)
$1.58B
Operating profit (TTM)
$273.60M
Net income (TTM)
$95.00M
Trailing 12 months
Diluted EPS (TTM)
$0.58
FCF margin
8.7%
Effective tax rate
59.4%

Per share

11 metrics
Revenue per diluted share (TTM)
$17.21
Gross profit per diluted share (TTM)
$9.50
Operating profit per diluted share (TTM)
$1.65
EBITDA per diluted share (TTM)
$2.34
Net income per diluted share (TTM)
$0.57
Operating cash flow per diluted share (TTM)
$1.83
Free cash flow per diluted share (TTM)
$1.50
Capital expenditures per diluted share (TTM)
$0.33
R&D per diluted share (TTM)
$0.73
Stock compensation per diluted share (TTM)
$0.24
Book value per share
$18.96

Growth

11 metrics
Revenue growth YoY
+7.1%
Year over year
Net income growth YoY
+103.4%
Revenue (TTM)
$2.86B
Trailing 12 months
EPS growth YoY
+106.3%
Shares change YoY
-3.4%
Year over year · fewer shares
Revenue CAGR (3Y)
+1.9%
Revenue CAGR (5Y)
+7.1%
EPS CAGR (3Y)
-41.1%
EPS CAGR (5Y)
+7.0%
FCF CAGR (3Y)
+29.1%
FCF CAGR (5Y)
-0.5%

Quality

14 metrics
Return on equity
3.1%
Return on assets
1.7%
Debt / equity
0.5
Current ratio
2.4
EBITDA (TTM)
$388.90M
Free cash flow (TTM)
$248.10M
Quick ratio
2.1
Interest coverage
—
Net debt / EBITDA
0.6
Return on invested capital
3.3%
Trailing 12 months
Net cash
−$236.60M
Latest balance sheet
Cash & equivalents
$1.13B
Total assets
$5.60B
Total debt
$1.45B

Cash flow & spend

7 metrics
Operating cash flow (TTM)
$302.60M
Capital expenditures (TTM)
$54.50M
R&D (TTM)
$120.80M
SG&A (TTM)
$1.18B
Stock compensation (TTM)
$40.50M
R&D / revenue
4.2%
Stock compensation / revenue
1.4%

Ownership (13F)

9 metrics
13F filers
383
13F filer change QoQ
-9
Institutional ownership
118.3%
Conviction holders (share of 13F filers)
1.0%
Crowding (high-turnover and private-fund holders)
—
Private-fund adviser ownership
—
Active holders' share change QoQ
+8.9%
Holder tenure
15.5
Price vs estimated holder cost
+8.9%

Ownership (registered funds)

1 metrics
Index-fund ownership
21.2%

Short interest

3 metrics
Short interest
7.5%
Latest settlement · 3.6 days to cover
Days to cover
3.6d
Short-squeeze score
60 / 100

Insider activity

2 metrics
Net insider buying (90D)
−$220,000
Insider-sentiment score
—

Risk flags

1 metrics
Going concern
—
Key facts CIK 1757073 CUSIP 29415F104 13F (30d) 49 filings 49 filers Visit website Investor relations